Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120826083 | 12082608 | 3 | F | 201604 | 20160815 | 20160217 | 20160819 | EXP | CA-ROCHE-1712507 | ROCHE | 29.03 | YR | F | Y | 0.00000 | 20160819 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120826083 | 12082608 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 120826083 | 12082608 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 120826083 | 12082608 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B | 103976 | SOLUTION FOR INJECTION | ||||||||
| 120826083 | 12082608 | 4 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 120826083 | 12082608 | 5 | C | VENTOLINE | ALBUTEROL | 1 | 0 | ||||||||||||
| 120826083 | 12082608 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 120826083 | 12082608 | 7 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120826083 | 12082608 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120826083 | 12082608 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120826083 | 12082608 | Asthma | |
| 120826083 | 12082608 | Bronchitis | |
| 120826083 | 12082608 | Forced expiratory volume decreased | |
| 120826083 | 12082608 | Headache | |
| 120826083 | 12082608 | Lung disorder | |
| 120826083 | 12082608 | Nasal congestion | |
| 120826083 | 12082608 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120826083 | 12082608 | 1 | 20150721 | 0 | ||
| 120826083 | 12082608 | 2 | 20160112 | 0 | ||
| 120826083 | 12082608 | 3 | 20160503 | 0 |